Category: Workers Comp

599 posts found

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.

NCCI Publishes 2025 Regulatory and Legislative Trends Report

NCCI tracked 950 bills impacting workers’ comp, highlighting key trends across the country, such as PTSD and cancer presumptions, worker classification, and psychedelics.

Clinical Insights

CWCI Study Finds Poor Performance Across Functional Restoration Programs

Claims in FRPs cost 59% more, likely tied to a gap between guideline recommendations and how FRPs are managed.

Healthe Developments

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2025!

Visit Healthe at Booth #1523 to chat and pick up a copy of RxInformer magazine. Don’t forget about our educational session!

Medmonitor

Generic Saxenda Delivers First GLP-1 Generic for Obesity

The approval of generic liraglutide injections address increased demand for GLP-1 receptor antagonist drugs.

This Month's Must Read

PBMs Explained: What Roles Can Pharmacy Benefit Managers Play in Workers’ Comp?

How PBMs help manage overall utilization, cost, and quality of workers’ comp healthcare.

Image of Someone experiencing mental turmoil

Legislation & Policy

PTSD Developments

New Jersey enacts counseling requirements, Minnesota publishes a report evaluating PTSD claims, and Washington proposes clinical guidelines.

image of Construction workers in the hot sun

Industry Trends

Heat-Related Injuries and Illnesses Among Construction Workers

According to the CPWR, construction workers make up 7% of the workforce, but over one-third of heat-related deaths in the U.S.

Healthe Developments

Cybersecurity Strategies to Balance Innovation & Caution in the Age of AI

Healthesystems AVP of Information & Technology Security, Tony Brown, will speak about this topic at the 2025 IAIABC Convention.

Healthe Developments

Tracking Sub-Regulatory Changes in Workers’ Comp

Healthe’s VP of Industry and State Affairs, Sandy Shtab, shares her thoughts with Risk & Insurance magazine in a recent article.

Medmonitor

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

All opioid manufacturers must update their drug labeling to align with a list of notes provided by the FDA.

This Month's Must Read

Burden of Proof: Unpacking Presumptions in Workers’ Comp

Exploring the expansion of presumptions in PTSD, cancers, and more.

Medmonitor

FDA Requires New Kidney Injury Warning for All GLP-1 Drugs

Dehydration from these drugs can lead to kidney damage, requiring hemodialysis treatment.

Clinical Insights

New Study Links Frequent Gabapentin Use to Higher Risk for Cognitive Impairment

Patients who had six or more gabapentin prescriptions were 85% more likely to experience mild cognitive impairment, and 29% were at higher risk for dementia.

Legislation & Policy

FDA Takes Steps to Restrict Certain Kratom Products

The FDA recommended concentrated 7-OH kratom products to be rescheduled under the Controlled Substances Act.

Prev 1 2 3 4 5 6 7 … 36 37 38 39 40 Next